Jörg Halter

7.7k total citations
161 papers, 3.5k citations indexed

About

Jörg Halter is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Jörg Halter has authored 161 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Hematology, 34 papers in Oncology and 31 papers in Epidemiology. Recurrent topics in Jörg Halter's work include Hematopoietic Stem Cell Transplantation (76 papers), Acute Myeloid Leukemia Research (30 papers) and Renal Transplantation Outcomes and Treatments (20 papers). Jörg Halter is often cited by papers focused on Hematopoietic Stem Cell Transplantation (76 papers), Acute Myeloid Leukemia Research (30 papers) and Renal Transplantation Outcomes and Treatments (20 papers). Jörg Halter collaborates with scholars based in Switzerland, Germany and United States. Jörg Halter's co-authors include Aloïs Gratwohl, Jakob Passweg, Dominik Heim, André Tichelli, Sabine Gerull, Urs Schanz, Hans H. Hirsch, Nina Khanna, Andreas Buser and Hildegard Greinix and has published in prestigious journals such as The Lancet, JAMA and Blood.

In The Last Decade

Jörg Halter

153 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörg Halter Switzerland 33 1.6k 839 685 624 545 161 3.5k
Urs Schanz Switzerland 31 1.6k 1.0× 463 0.6× 551 0.8× 521 0.8× 351 0.6× 133 3.2k
Daniel Wolff Germany 35 2.9k 1.8× 544 0.6× 1.3k 1.9× 1.3k 2.1× 742 1.4× 214 5.0k
Yves Chalandon Switzerland 34 2.3k 1.4× 728 0.9× 995 1.5× 761 1.2× 1.4k 2.6× 192 4.3k
Jason W. Chien United States 38 2.4k 1.4× 1.5k 1.8× 1.1k 1.6× 804 1.3× 733 1.3× 109 6.0k
Yi‐Bin Chen United States 35 2.1k 1.3× 557 0.7× 1.5k 2.2× 1.1k 1.8× 561 1.0× 197 4.9k
Haydar Frangoul United States 27 1.1k 0.7× 437 0.5× 422 0.6× 490 0.8× 490 0.9× 131 2.4k
Martin Stern Switzerland 36 1.7k 1.1× 976 1.2× 774 1.1× 1.5k 2.4× 343 0.6× 135 5.0k
R Miniero Italy 27 1.4k 0.9× 371 0.4× 630 0.9× 724 1.2× 711 1.3× 165 3.8k
A Oakhill United Kingdom 36 1.4k 0.8× 625 0.7× 709 1.0× 435 0.7× 1.1k 1.9× 97 3.6k
Theresa Hahn United States 32 1.9k 1.2× 350 0.4× 1.1k 1.5× 464 0.7× 1.1k 2.0× 142 3.6k

Countries citing papers authored by Jörg Halter

Since Specialization
Citations

This map shows the geographic impact of Jörg Halter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Halter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Halter more than expected).

Fields of papers citing papers by Jörg Halter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Halter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Halter. The network helps show where Jörg Halter may publish in the future.

Co-authorship network of co-authors of Jörg Halter

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Halter. A scholar is included among the top collaborators of Jörg Halter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Halter. Jörg Halter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halter, Jörg, Friedrich Stölzel, Markus Perl, et al.. (2025). Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis. Bone Marrow Transplantation. 60(4). 439–446. 6 indexed citations
2.
Hoffmann, Michèle J., Yara Banz, Jörg Halter, et al.. (2024). True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations—Brief Report. Current Oncology. 31(4). 2067–2075.
3.
Volken, Thomas, Beatrice Drexler, Laura Infanti, et al.. (2023). Safety and Feasibility of Immunoadsorption with Heparin Anticoagulation in Preparation of ABO-Incompatible Kidney Transplantation: A Retrospective Single-Center Study. Transfusion Medicine and Hemotherapy. 50(2). 76–87. 2 indexed citations
4.
Zuern, Christine S., et al.. (2023). Case report: mRNA-1273 COVID-19 vaccine-associated myopericarditis: Successful treatment and re-exposure with colchicine. Frontiers in Cardiovascular Medicine. 10. 1135848–1135848. 2 indexed citations
5.
Syedbasha, Mohammedyaseen, et al.. (2022). Model-based inference of neutralizing antibody avidities against influenza virus. PLoS Pathogens. 18(1). e1010243–e1010243. 3 indexed citations
6.
Medinger, Michael, Dominik Heim, Helen Baldomero, et al.. (2022). Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study. Bone Marrow Transplantation. 57(4). 613–619. 6 indexed citations
7.
Leuzinger, Karoline, et al.. (2022). Antibody response to mRNA SARS‐CoV‐2 vaccination in 182 patients after allogeneic hematopoietic cell transplantation. Transplant Infectious Disease. 24(3). e13828–e13828. 10 indexed citations
8.
Volken, Thomas, Jakob Passweg, Jörg Halter, et al.. (2021). Frequency, reactivity and evolution of human leukocyte antigen and human platelet antigen antibodies in the setting of hematopoietic cell transplantation. Transfusion and Apheresis Science. 61(2). 103301–103301. 1 indexed citations
9.
Bühler, Stéphane, Helen Baldomero, Sylvie Ferrari‐Lacraz, et al.. (2021). Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation. Blood Advances. 5(17). 3377–3386. 8 indexed citations
10.
Lundberg, Pontus, Alexandar Tzankov, Martina Kleber, et al.. (2020). Secondary CNL after SAA reveals insights in leukemic transformation of bone marrow failure syndromes. Blood Advances. 4(21). 5540–5546. 2 indexed citations
11.
Sugrue, Michele W., Jay S. Raval, Kevin J. Land, et al.. (2020). Adverse event reporting for cellular therapy products: Current status and future directions. Transfusion. 60(12). 2815–2827. 2 indexed citations
12.
Tschudin‐Sutter, Sarah, Francesca Compagno, Michael Tamm, et al.. (2018). Community-Acquired Respiratory Paramyxovirus Infection After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience. Open Forum Infectious Diseases. 5(5). ofy077–ofy077. 29 indexed citations
13.
14.
Tamm, Michael, Kathleen Jahn, Jörg Halter, et al.. (2014). Galactomannan in Bronchoalveolar Lavage for Diagnosing Invasive Fungal Disease. American Journal of Respiratory and Critical Care Medicine. 190(3). 309–317. 34 indexed citations
15.
Egli, Adrian, Christoph Bucher, Alexis Dumoulin, et al.. (2012). Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection. 40(6). 677–684. 33 indexed citations
16.
Hilgendorf, Inken, Mathias Freund, Wolfgang Jilg, et al.. (2011). Vaccination of allogeneic haematopoietic stem cell transplant recipients: Report from the International Consensus Conference on Clinical Practice in chronic GVHD. Vaccine. 29(16). 2825–2833. 65 indexed citations
17.
Cámara, Rafael de la, Manuel Abecasis, Catherine Cordonnier, et al.. (2011). Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica. 96(8). 1231–1235. 83 indexed citations
18.
Halter, Jörg, Dominik Heim, Jakob Passweg, et al.. (2011). Pre-emptive diagnosis and treatment of fungal infections—evaluation of a single-centre policy. Clinical Microbiology and Infection. 18(2). 189–194. 8 indexed citations
19.
Rovó, Alicia, Thomas Daikeler, Jörg Halter, et al.. (2010). Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor. Haematologica. 96(1). 150–155. 22 indexed citations
20.
Tichelli, André, Christoph Bucher, Alicia Rovó, et al.. (2007). Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood. 110(9). 3463–3471. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Urs Schanz Breakdown of academic impact, for papers by Daniel Wolff Breakdown of academic impact, for papers by Yves Chalandon Breakdown of academic impact, for papers by Jason W. Chien Breakdown of academic impact, for papers by Yi‐Bin Chen Breakdown of academic impact, for papers by Haydar Frangoul Breakdown of academic impact, for papers by Martin Stern Breakdown of academic impact, for papers by R Miniero Breakdown of academic impact, for papers by A Oakhill Breakdown of academic impact, for papers by Theresa Hahn
Rankless by CCL
2026